Further work is required to clarify the roles of other major protagonists, particularly looking at the nuanced role of oestrogen in different tumour types, thinking laterally about how to measure the true effects of IGF-1 in obesity and measuring markers of insulin signalling over time in human obesogenic tumour sites. The gene discussed is INS; the disease is obesity disorder.